Trials / Completed
CompletedNCT01276743
Study of PTPN22 C1858T Polymorphism in Children and Adolescents of Greek Origin With T1DM
Study of Protein Tyrosine Phosphatase Non-receptor Type 22 (PTPN22) C1858T Polymorphism in Children and Adolescents of Greek Origin With Type 1 Diabetes Mellitus (T1DM)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (actual)
- Sponsor
- Aristotle University Of Thessaloniki · Academic / Other
- Sex
- All
- Age
- 3 Years – 18 Years
- Healthy volunteers
- Accepted
Summary
The protein tyrosine phosphatase non-receptor type 22 (PTPN22) gene encodes a lymphoid-specific phosphatase (LYP) which is an important downregulatory factor of T cell activation. A PTPN22 polymorphism, C1858T, was found associated with T1DM in different Caucasian populations. In this observational case-control study, we aimed at confirming the role of PTPN22, C1858T polymorphism in T1DM predisposition in a Greek population.
Conditions
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2011-07-01
- Completion
- 2013-02-01
- First posted
- 2011-01-13
- Last updated
- 2014-02-28
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT01276743. Inclusion in this directory is not an endorsement.